# Intracoronary Injection of Epo After Myocardial Infarct "Intra-CO-EpoMI"

> **NCT01043991** · PHASE3 · COMPLETED · sponsor: **University Hospital, Montpellier** · enrollment: 54 (actual)

## Conditions studied

- Acute Myocardial Infarct

## Interventions

- **DRUG:** Darbepoetin alfa
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01043991
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12
- **Primary completion:** 2010-07
- **Final completion:** 2011-10
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2016-06-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01043991

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01043991, "Intracoronary Injection of Epo After Myocardial Infarct "Intra-CO-EpoMI"". Retrieved via AI Analytics 2026-07-08 from https://api.ai-analytics.org/clinical/NCT01043991. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*